Titan Pharmaceuticals, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-10-04: Reporting owner Sire Group Ltd. | Shen Seow Gim; Form 3; Security "Series AA Convertible Preferred Stock (""Preferred Stock"")"; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-10-04 holding as of filing | Sire Group Ltd. | Shen Seow Gim 10% Owner | 10% Owner | 3 | "Series AA Convertible Preferred Stock (""Preferred Stock"")" Derivative · Direct | Holding | $0.47 exercise price | 2023-10-04 |